Delayed Diagnosis of Symptomatic Breast Cancer
Abstract Misdiagnosis or delay in diagnosis of breast cancer is one of the most common causes of malpractice litigation. Many different issues account for the number of legal cases related…
Breast Cancer Survivorship
Abstract Attention to issues related to breast cancer survivorship is important to optimize oncologic outcomes and quality of life. Patients, cancer care providers, and primary care providers must work collaboratively…
Psychosocial Consequences and Lifestyle Interventions
Abstract The diagnosis of breast cancer generates significant distress in the lives of patients and their families because cancer is often considered synonymous with death, pain, and suffering. The first…
Rehabilitation
Abstract It has been demonstrated that as a result of breast cancer and its treatment, survivors of the disease experience a high prevalence of functional impairments. Survivors may experience short-term,…
Management of Menopause in the Breast Cancer Patient
Abstract Many women with breast cancer are menopausal at the time of their cancer diagnosis, and a significant number will enter menopause during treatment. Achievement of adequate control of menopausal…
General Considerations for Follow-Up
Abstract Most women treated for early-stage breast cancer will be long-term survivors. In 2016 more than 3.5 million breast cancer survivors were expected in the United States alone and millions…
Unknown Primary Presenting With Axillary Lymphadenopathy
Abstract Breast cancer can rarely present as isolated axillary adenopathy without any evidence of a primary breast mass creating many diagnostic and therapeutic challenges. Occult breast cancer is defined as…
Clinical Management of the Patient at Increased or High Risk
Abstract There are now interventions to reduce a woman’s chance of being diagnosed with breast cancer as well as strategies for the screening of increased or high-risk women. It is…
Chemotherapy and HER2-Directed Therapy for Metastatic Breast Cancer
Abstract Chemotherapy and HER2-directed therapy for metastatic breast cancer represent an important and quickly evolving area. Much of the significant progress since 2010 has focused on advances in HER2-directed therapy,…
Bisphosphonates in Early Breast Cancer
Abstract Bisphosphonates are osteoclast inhibitors used to treat osteoporosis. In oncology, bisphosphonates are used to prevent or treat skeletal-related events such as pathologic fractures and hypercalcemia of malignancy. In early…
